跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
氨吡啶缓释片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Fampridine Sustained-release Tablets
Approved
化学药品
Fampridine Sustained-release Tablets
Biogen Netherlands BV
🇨🇳 National Medical Products Administration
Approval Date
May 11, 2021
Approval ID
887NbT7T1I3
Company
Biogen Netherlands BV
Type
化学药品
Approval Details
Approval Id
887NbT7T1I3
Approval Number
国药准字HJ20210031
Generic Name
氨吡啶缓释片
Generic Name En
Fampridine Sustained-release Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
10mg
Reg Date
2021-05-11
Expired Date
2026-05-10
Company Name
Biogen Netherlands BV
Company Address
Prins Mauritslaan 13,1171 LP Badhoevedorp, The Netherlands
Production Company Name
alkermes pharma ireland ltd
Production Company Address
Monksland, Athlone, Co. Westmeath, Ireland
Company Detail Path
/organization/biogen-netherlands-bv
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 11, 2021
Approval ID
887NbT7T1I3
Type
化学药品
Back to NMPA Approvals